Search
for
Sort by
Research 151–180 of 1000+
- Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation
- Clinical development and management of adverse events associated with FGFR inhibitors
- Cutaneous side-effects of EGFR inhibitors and their management.
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots
- Hair growth promotion by Necrostatin-1s
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- Udenafil Induces the Hair Growth Effect of Adipose-Derived Stem Cells
- Transient treatment of pregnant Merino ewes with modulators of cortisol biosynthesis coinciding with primary wool follicle initiation alters lifetime wool growth
- iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice
- Experience in treating multifocal alopecia areata in a child with Jak kinase inhibitors
- ISID1338 - Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- 1338 Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- Study on Antioxidants and Growth Factors in the Treatment of Alopecia with Injectables
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- The effects of extra cellular matrix and growth factors on dermal papilla cell proliferation
- l-Ascorbic acid 2-phosphate promotes elongation of hair shafts via the secretion of insulin-like growth factor-1 from dermal papilla cells through phosphatidylinositol 3-kinase
- Exosomal miRNA-181a-5p from the cells of the hair follicle dermal papilla promotes the hair follicle growth and development via the Wnt/β-catenin signaling pathway
- TNF‐inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- ROCK inhibitor Y-27632 maintains the propagation and characteristics of hair follicle stem cells.
- An epidermis‐permeable dipeptide is a potential cosmetic ingredient with partial agonist/antagonist activity toward fibroblast growth factor receptors
- 873 The effect of Cilostazol on hair growth: A novel therapeutic option for the treatment of hair loss
- Expression of nerve growth factor in skin tissues and its effect on the proliferation of outer root sheath cells in cashmere goats
- Corticotropin-Releasing Factor Down-Regulates Hair Growth-Related Cytokines in Cultured Human Dermal Papilla Cells